Table 3.
Comparison of sarcoidosis and HP subgroups.
| Sarcoidosis: stage I versus stage II | Sarcoidosis: with versus without Lӧfgren syndrome | HP: stage inflammatory versus fibrotic | Sarcoidosis stage I and II versus inflammatory HP | |
|---|---|---|---|---|
| TREM-1% | 80.5/18.4/ vs 73.1 /20.2/ | 79.5/19.2/ vs 76.1/21.9/ | 37.3/38.8/ vs 30.8/32.3/ | 76.7/21.2/ vs 26.3/52.8/ |
| Median/IQR/ | P = 0.005 | P = 0.1623 | P = 0.7345 | P = 0.0002 |
| TREM-1 MFI | 44.4/24.5/ vs 39.5/24.3/ | 39.6/22.0/ vs 40.9/24.3/ | 26.9/39.1/ vs 24.8/20.7/ | 40.7/23.3/ vs 25.7/38.8/ |
| Median/IQR/ | P = 0.1985 | P = 0.6262 | P = 0.8078 | P = 0.0395 |
| TREM-2% | 37.4/42.1/ vs 26.6/37.7/ | 34.6/36.5/ vs 35.0/39.9/ | 40.1/65.2/ vs 45.5/31.4/ | 34.7/39.0/ vs 34.2/42.7/ |
| Median/IQR/ | P = 0.0648 | P = 0.7218 | P = 0.5091 | P = 0.9143 |
| TREM-2 MFI | 8.35/4.0/ vs 7.8/3.4/ | 4.8/3.1/ vs 5.0/4.2/ | 7.0/4.8/ vs 7.1/5.3/ | 5.1/3.9/ vs 6.7/4.6/ |
| Median/IQR/ | P = 0.0654 | P = 0.7433 | P = 0.8156 | P = 0.6845 |